GKOS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 22:59):

Stats
Dzisiejszy wolumen	586 384
Średni wolumen	502 818
Kapitalizacja rynkowa	4.97B
EPS	$0 ( 2024-02-21 )
Następna data zysków	( $-0.580 ) 2024-05-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-35.59
ATR14	$0.283 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Hoffmeister David F	Buy	10 000	Common Stock
2024-04-10	Hoffmeister David F	Sell	10 000	Stock Option (Right to Buy)
2024-04-08	Gilliam Joseph E	Buy	59 801	Common Stock
2024-04-08	Gilliam Joseph E	Sell	10 456	Common Stock
2024-04-08	Gilliam Joseph E	Sell	41 068	Common Stock

INSIDER POWER
0.86
Last 100 transactions
Buy: 501 923 \| Sell: 495 631

Wolumen Korelacja

Długi: -0.25 (neutral)

Krótki: 0.10 (neutral)

Signal:(31.54) Neutral

Glaukos Corp Korelacja

10 Najbardziej pozytywne korelacje
HDIV	0.826
LXFR	0.808
NXN	0.804
BFS-PD	0.803

10 Najbardziej negatywne korelacje
FORG	-0.813

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Glaukos Corp Korelacja - Waluta/Towar

-0.44
( neutral )

0.21
( neutral )

0.06
( neutral )

0.73
( moderate )

0.51
( weak )

Glaukos Corp Finanse

Annual	2023
Przychody:	$314.71M
Zysk brutto:	$239.14M (75.99 %)
EPS:	$-2.78

FY	2023
Przychody:	$314.71M
Zysk brutto:	$239.14M (75.99 %)
EPS:	$-2.78

FY	2022
Przychody:	$282.86M
Zysk brutto:	$213.88M (75.61 %)
EPS:	$-2.09

FY	2021
Przychody:	$294.01M
Zysk brutto:	$227.38M (77.34 %)
EPS:	$-1.070

Financial Reports:

No articles found.

Glaukos Corp

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Aktualne aktualizacje dla Glaukos Corp [GKOS]

Upcoming Earnings Alert